Notice of Early Termination of NOT-TR-21-017, Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs
Notice Number:
NOT-TR-23-023

Key Dates

Release Date:

June 22, 2023

Related Announcements

  • February 3, 2021 - Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs. See Notice NOT-TR-21-017.
  • March 1, 2023 - Expiration of the COVID-19 Public Health Emergency. See Notice NOT-OD-23-095.

Issued by

National Center for Advancing Translational Sciences (NCATS)

Purpose

The National Center for Advancing Translational Sciences (NCATS) announces the early termination of NOT-TR-21-017 Notice of Special Interest (NOSI): Administrative Supplements for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs. NCATS will not accept applications for administrative supplements in response to NOT-TR-21-017 effective immediately due to the end of the declared public health emergency as stated in NOT-OD-23-095 “Expiration of the COVID-19 Public Health Emergency”.
 

This Notice does not affect other applications in response to PA-20-272 (Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional). 

Inquiries

Please direct all inquiries to:

Please direct all inquiries to the contacts in Section VII of the listed funding opportunity announcements with the following additions/substitutions:

Scientific/Research Contact(s)

Please contact the program officer on your active award.

Financial/Grants Management Contact(s)

Please contact the grants specialist on your active award.